Interview with Dimitrios Kontoyiannis, Professor and Robert C. Hickey Chair in Clinical ...
New long-term data from Eli Lilly and Company showed Omvoh (mirikizumab-mrkz) delivered durable efficacy through three years in adults with moderately to severely active Crohn's disease.1 These data ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance to even last-line ...
In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...
NEW YORK, Feb 10 : Major stock indexes were mixed on Tuesday, with a world equity index and the Dow Jones industrial average hitting record highs although other key U.S. indexes weakened, while ...